tiprankstipranks
Marechale Capital PLC (GB:MAC)
LSE:MAC
UK Market
Want to see GB:MAC full AI Analyst Report?

Marechale Capital (MAC) AI Stock Analysis

5 Followers

Top Page

GB:MAC

Marechale Capital

(LSE:MAC)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
1.50 p
▼(-68.42% Downside)
Action:Reiterated
Date:01/08/26
The score is primarily held back by weak financial performance (negative margins and persistently negative operating/free cash flow), with only moderate support from technical strength (price above key moving averages but overbought RSI). Valuation is also constrained by a negative P/E reflecting losses.
Positive Factors
Low leverage / strong equity ratio
Conservative leverage and a strong equity ratio provide durable financial flexibility. With lower refinancing risk and a solid capital base, the company can better absorb revenue volatility, fund necessary restructurings or opportunistic investments, and buy time to restore profitability.
Negative Factors
Persistent negative cash flows
Sustained negative operating and free cash flows erode liquidity and force reliance on external financing or asset draws. Over a multi‑month horizon this limits the ability to invest, respond to competitive threats, and execute strategic initiatives, making recovery and growth harder to fund internally.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong equity ratio
Conservative leverage and a strong equity ratio provide durable financial flexibility. With lower refinancing risk and a solid capital base, the company can better absorb revenue volatility, fund necessary restructurings or opportunistic investments, and buy time to restore profitability.
Read all positive factors

Marechale Capital (MAC) vs. iShares MSCI United Kingdom ETF (EWC)

Marechale Capital Business Overview & Revenue Model

Company Description
Marechale Capital Plc, a corporate finance firm established in 1998 and based in London, provides an array of financial services throughout the United Kingdom and Europe. The company specializes in delivering strategic guidance, merger and acquisi...
How the Company Makes Money
null...

Marechale Capital Financial Statement Overview

Summary
Weak profitability and cash generation drive the score: revenue fell 17.53% most recently, margins are negative, and operating/free cash flow remain negative. The balance sheet is comparatively steadier with low leverage and a strong equity ratio, but negative ROE signals poor returns on capital.
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
40
Negative
BreakdownTTMApr 2024Apr 2023Apr 2022Apr 2021Apr 2020
Income Statement
Total Revenue373.10K409.41K668.82K375.73K621.57K398.45K
Gross Profit316.48K409.41K197.38K97.07K329.94K253.95K
EBITDA-336.76K-338.30K-182.56K-52.12K2.72M202.59K
Net Income-335.58K-337.32K-182.99K-425.52K2.56M245.89K
Balance Sheet
Total Assets3.19M3.18M3.43M3.35M3.73M796.97K
Cash, Cash Equivalents and Short-Term Investments3.04M3.02M3.29M3.15M3.54M656.36K
Total Debt7.50K2.50K22.50K32.50K42.50K50.00K
Total Liabilities123.20K145.99K84.53K124.06K99.87K111.21K
Stockholders Equity3.06M3.04M3.35M3.23M3.63M685.75K
Cash Flow
Free Cash Flow-238.85K-185.71K-256.06K-367.22K-131.85K-92.51K
Operating Cash Flow-238.85K-185.71K-256.06K-367.22K-131.85K-191.79K
Investing Cash Flow50.00K160.08K-3.64K226.93K-42.46K-49.65K
Financing Cash Flow192.50K-10.41K225.10K-8.42K355.00K317.49K

Marechale Capital Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price4.75
Price Trends
50DMA
5.47
Negative
100DMA
3.68
Positive
200DMA
2.82
Positive
Market Momentum
MACD
-0.12
Negative
RSI
47.44
Neutral
STOCH
62.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MAC, the sentiment is Neutral. The current price of 4.75 is below the 20-day moving average (MA) of 4.99, below the 50-day MA of 5.47, and above the 200-day MA of 2.82, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 47.44 is Neutral, neither overbought nor oversold. The STOCH value of 62.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:MAC.

Marechale Capital Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
£113.16M7.7214.26%5.05%57.11%
61
Neutral
£3.58M0.9366.17%
60
Neutral
£34.90M54.411.45%8.42%2.19%-26.09%
56
Neutral
£13.67M3.2314.74%3.17%-37.49%
50
Neutral
£12.22M-14.84-10.57%-32.90%-57.89%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:MAC
Marechale Capital
4.75
2.70
131.71%
GB:JIM
Jarvis Securities
8.00
-15.00
-65.22%
GB:TAVI
Tavistock Investments
3.10
-0.71
-18.64%
GB:CAV
finnCap Group plc
9.75
-1.83
-15.80%
GB:PEEL
Peel Hunt Limited
96.50
4.03
4.35%

Marechale Capital Corporate Events

Business Operations and Strategy
Marechale Capital Unveils New Website to Highlight Digital Merchant Bank Strategy
Positive
Jul 28, 2026
Marechale Capital has launched a new corporate website designed to present a modernised, integrated view of its digital merchant banking operations and to showcase its strategy following the group’s recent transformation. The site consolidat...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Marechale Capital Grants 8.75 Million Share Options to Senior Management
Positive
Jul 13, 2026
Marechale Capital plc has granted 8,750,000 options over ordinary shares at an exercise price of 4.75 pence to directors, a PDMR and an employee, bringing total options in issue to 24,016,076, or about 9.33% of the current issued share capital. Th...
Business Operations and StrategyM&A TransactionsShareholder Meetings
Marechale Capital Completes Acquisitions to Build Full-Service Digital Merchant Bank
Positive
Jun 24, 2026
Marechale Capital has completed the acquisitions of Stanford Capital Partners, Blubird Global, Inc and NJC Capital, following shareholder approval at a general meeting on 22 June 2026. The enlarged group is positioning itself as one of the first f...
Other
Marechale Director Restructures Holding via Share Transfer and Sale
Neutral
Jun 23, 2026
Marechale Capital plc has disclosed that non-executive director Chris Kenning has transferred 9,146,670 ordinary shares in the company to 1Edge Insurance PCC Limited, a private vehicle indirectly controlled by him, and sold 3,000,000 shares to mee...
Business Operations and StrategyDelistings and Listing ChangesM&A TransactionsPrivate Placements and FinancingShareholder Meetings
Marechale wins shareholder backing for digital merchant bank expansion
Positive
Jun 22, 2026
Marechale Capital said shareholders have approved its proposed acquisitions and a conditional subscription, clearing the way for completion on 24 June 2026 and the admission of 137,846,002 new shares to trading on AIM. The enlarged group will brin...
Business Operations and StrategyM&A TransactionsRegulatory Filings and ComplianceShareholder Meetings
Marechale Capital Wins FCA Nod for Stanford Control Shift Ahead of Transformational Deal Vote
Positive
Jun 8, 2026
Marechale Capital has secured approval from the UK Financial Conduct Authority for a change of control at Stanford Capital Partners, a key condition in a broader series of proposed acquisitions announced earlier this month. The FCA decision clears...
Business Operations and StrategyExecutive/Board ChangesM&A TransactionsPrivate Placements and FinancingShareholder Meetings
Marechale Capital moves to build listed digital merchant bank with trio of acquisitions
Positive
Jun 3, 2026
Marechale Capital has agreed to acquire Stanford Capital Partners, Blubird Global and NJC Capital, in an all-share deal issuing over 75 million new shares, as it seeks to build one of the UK’s first publicly quoted, fully integrated digital ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 08, 2026